"We are focused on solutions for children and babies as well, avoiding the use of corticosteroids."
In Conversation
"One of our key priorities will be around new initiatives that will ensure we continue to be a strong player in the renal space in Canada."
"When looking at the Balkan region, the Serbian pharmaceutical market is still underdeveloped and offers the most potential in terms of future development."
"The clinical trials space in India is still emerging and we do think that the market will continue opening up."
"We are absolutely concentrated in the private sector as the public sector in Poland does not historically partner with consultancy firms."
"Our objective moving forward is very clear: continue bringing innovation in all our areas and make ISDIN a strong reference in the Brazilian market."
"Pediapharm is unique, in that we master the pediatric market in Canada and are able to bring all key stakeholders in the field together and draw…
"The market of clinical research is quite small in Lithuania, but the research-based players are being quite active in this front with clinical trial investments at…
"The central part of the spirit of Debiotech is to have an impact, and not just gain financial revenues."
"We are still at the beginning of our partnership acquisition and have recognized that the market is stable – even promising."
"Our country has made huge progress, and I see the recent economic turmoil as an evidence that Brazil is finally tackling long-lasting corruption problems."
"Poland finds itself in a unique position, and we believe we have the chance to be considered as a hub for cardiovascular activity."
